Kindred Biosciences, Inc. KIN
9.25 +9.25
Day range unavailable
52-week range unavailable
News
prnewswire.com SHAREHOLDER ALERT: WeissLaw LLP Reminds CVA, SWN, RIVE, and KIN Shareholders About Its Ongoing Investigations NEW YORK, July 21, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights…
prnewswire.com Moore Kuehn Encourages KIN, SVOK, ROCR, and DCRC Investors to Contact Law Firm NEW YORK, June 22, 2021 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning…
businesswire.com KINDRED BIOSCIENCES INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kindred Biosciences, Inc. - KIN NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Kindred…
benzinga.com Stocks That Hit 52-Week Highs On Thursday This morning 94 companies set new 52-week highs.
prnewswire.com SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Kindred Biosciences, Inc. - KIN NEW YORK, June 16, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class…
fool.com Why Kindred Biosciences Stock Skyrocketed Today The pet therapeutics pioneer is being scooped up by a global animal health leader.
invezz.com Kindred Biosciences to merge with Elanco Animal Health Elanco Animal Health Inc (NYSE: ELAN) said on Wednesday it will acquire Kindred Biosciences Inc (NASDAQ: KIN) for roughly $440 million (£312 million) to expand its footprint in the pet health…
benzinga.com Why Kindred Biosciences, Aprea, Catabasis And Inhibikase Are Moving Today Kindred Biosciences, Inc. (NASDAQ: KIN), Aprea Therapeutics, Inc. (NASDAQ: APRE), Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) and Inhibikase Therapeutics, Inc. (NASDAQ: IKT) are among the biggest…
businesswire.com Kindred Biosciences Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Kindred Biosciences, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – KIN NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Kindred Biosciences, Inc. (NASDAQ: KIN) to Elanco Animal Health Incorporated for…
benzinga.com Stocks That Hit 52-Week Highs On Wednesday Before 10 a.m. ET on Wednesday, 105 companies hit new 52-week highs.
pulse2.com KIN Stock Price Increases Over 45% Pre-Market: Why It Happened The stock price of Kindred Biosciences Inc (NASDAQ: KIN) increased by over 45% pre-market. This is why it happened.
marketwatch.com Elanco Animal Health to acquire Kindred Biosciences for about $440 million; Kindred shares soar 45% premarket Elanco Animal Health Inc. said Wednesday it has entered an agreement to acquire Kindred Biosciences Inc. for about $440 million, adding three potential dermatology blockbusters to its pipeline. Under…
prnewswire.com Elanco Announces Agreement to Acquire Kindred Biosciences GREENFIELD, Ind. and SAN FRANCISCO, June 16, 2021 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) and Kindred Biosciences, Inc. (KindredBio, NASDAQ: KIN) today announced the parties…
benzinga.com 55 Biggest Movers From Yesterday Gainers DLocal Limited (NASDAQ: DLO) shares jumped 54.2% to close at $32.39 on Thursday. DLocal raised around $92.6 million from the sale of 4.4 million shares in its IPO.
benzinga.com Stocks That Hit 52-Week Highs On Thursday Before 10 a.m. ET on Thursday, 86 companies set new 52-week highs.
zacks.com Kindred Bio (KIN) Soars 16%: Is Further Upside Left in the Stock? Kindred Bio (KIN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase…
prnewswire.com Kindred Biosciences to Present at Stifel 2021 Virtual Jaws & Paws Conference and LD Micro Invitational XI SAN FRANCISCO, May 25, 2021 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will present at the Stifel 2021…
seekingalpha.com Kindred Biosciences, Inc. (KIN) CEO Dr. Richard Chin on Q1 2021 Results - Earnings Call Transcript Kindred Biosciences, Inc. (KIN) CEO Dr. Richard Chin on Q1 2021 Results - Earnings Call Transcript
prnewswire.com Kindred Biosciences Announces First Quarter 2021 Financial Results SAN FRANCISCO, May 11, 2021 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial results…- benzinga.com Earnings Scheduled For May 11, 2021 Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter.
prnewswire.com Kindred Biosciences to Announce First Quarter 2021 Financial Results SAN FRANCISCO, May 3, 2021 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will release its first quarter 2021…
seekingalpha.com Week 18 MDA Breakout Stocks - May 2021: Short-Term Picks To Give You An Edge Week 18 MDA Breakout Stocks - May 2021: Short-Term Picks To Give You An Edge
zacks.com Kindred Biosciences (KIN) May Report Negative Earnings: Know the Trend Ahead of Q1 Release Kindred Bio (KIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
gurufocus.com Steven Cohen Adopts Stake in Kindred Biosciences Point72 Asset Management leader Steven Cohen (Trades, Portfolio) disclosed a 9.31% stake in Kindred Biosciences Inc. (NASDAQ:KIN) earlier this week.
seekingalpha.com Kindred Biosciences, Inc. (KIN) CEO Richard Chin on Q4 2020 Results - Earnings Call Transcript Kindred Biosciences, Inc. (KIN) CEO Richard Chin on Q4 2020 Results - Earnings Call Transcript
benzinga.com Earnings Scheduled For November 9, 2020 Companies Reporting Before The Bell • General Finance (NASDAQ:GFN) is projected to report quarterly earnings at $0.03 per share on revenue of $77.42 million. • Stratus Properties (NASDAQ:STRS) is…
benzinga.com 60 Biggest Movers From Yesterday Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares jumped 171.6% to close at $34.22 on Monday after Nestle SA agreed to acquire the company at an enterprise value of $2.6 billion.- benzinga.com 50 Stocks Moving In Monday's Mid-Day Session Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares climbed 171.5% to $34.21 after Nestle SA agreed to acquire the company at an enterprise value of $2.6 billion.
- benzinga.com 130 Biggest Movers From Yesterday
- benzinga.com 94 Stocks Moving In Tuesday's Mid-Day Session
- benzinga.com Stocks That Hit 52-Week Lows On Monday
- benzinga.com List of Companies Reaching Yearly Lows Tuesday
- benzinga.com 64 Biggest Movers From Yesterday
benzinga.com 51 Stocks Moving In Thursday's Mid-Day Session - benzinga.com 82 Biggest Movers From Yesterday
- benzinga.com Stocks Which Set New 52-Week High Yesterday, August 6th
- benzinga.com Stocks Which Set New 52-Week High Yesterday, August 1st
- benzinga.com Stocks Which Set New 52-Week High Yesterday:
- benzinga.com Stocks Which Set New 52-Week High Yesterday